Gastrointestinal Blood Loss in Arthritic Patients Receiving Chronic Dosing with Etodolac and Piroxicam
- 1 November 1986
- journal article
- clinical trial
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 292 (5) , 272-276
- https://doi.org/10.1097/00000441-198611000-00004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The efficacy of etodolac for patients with pain following oral surgeryJournal of Oral and Maxillofacial Surgery, 1984
- Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal MalesThe Journal of Clinical Pharmacology, 1984
- The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgeryOral Surgery, Oral Medicine, Oral Pathology, 1983
- Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac1 with several clinically effective anti-inflammatory drugsInflammation Research, 1982
- A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agentsDigestive Diseases and Sciences, 1979
- Anti-inflammatory and analgesic properties of etodolic acid in ratsCanadian Journal of Physiology and Pharmacology, 1976
- Gastrointestinal Blood Loss during Prolonged Aspirin AdministrationNew England Journal of Medicine, 1973
- A new method for studying gut transit times using radioopaque markersGut, 1969
- 1958 Revision of diagnostic criteria for rheumatoid arthritisArthritis & Rheumatism, 1959
- The Use of the Isotope 51Cr as a Label for Red CellsBritish Journal of Haematology, 1955